Today: 23 May 2026
European Stocks Climb Despite Shutdown Fears – Healthcare and Luxury Lead Gains
7 November 2025
3 mins read

Stock Market Today: Nasdaq Logs Worst Week Since April as AI Jitters Bite; Dow, S&P Edge Up — Nov. 7, 2025

Dateline: Friday, November 7, 2025

Key takeaways

  • Mixed close: S&P 500 (+0.13%) and Dow (+0.16%) eked out gains, while the Nasdaq (-0.21%) slipped—yet it sealed its worst week since April.
  • Mood sours:U.S. consumer sentiment plunged to 50.3, near a 3½‑year low, as the record government shutdown drags on.
  • Travel risk: FAA ordered initial 4% flight cuts Friday and the U.S. transportation chief warned reductions could reach 20% if the shutdown persists.
  • Tech pressure: Profit‑taking in AI and chip names kept a lid on risk appetite; Treasurys firmed and the dollar eased.
  • Stock movers:Expedia jumped on upbeat guidance; Block sank after results; Take‑Two fell on another GTA VI delay; Tesla shareholders approved Elon Musk’s $1T pay package.
  • Deal watch (Europe):Euronext cut the minimum acceptance threshold in its ATHEX tender to 50% + 1 share, keeping the bid alive.

Market snapshot

Wall Street finished the week with a split tape: the S&P 500 rose 0.13%, the Dow added 0.16%, and the Nasdaq slipped 0.21%. Under the hood, the growth complex remained heavy, capping the Nasdaq’s steepest weekly percentage drop since early April as investors reassessed the pace and durability of the AI‑led rally.

Macro drivers: confidence cracks, shutdown bites, dollar softens

The University of Michigan’s preliminary November sentiment reading tumbled to 50.3 (from 53.6), with respondents citing fallout from the longest U.S. government shutdown on record—a drag increasingly visible in day‑to‑day life and in the data vacuum left by halted federal releases. The current conditions gauge sank to an all‑time low in the survey’s history.

With risk appetite fading, Treasury yields edged lower and the U.S. dollar drifted as traders weighed a murky Fed path against soft private‑sector signals and weak China trade data.

Shutdown watch: aviation curbs escalate

The FAA mandated 4% cuts to flight schedules at 40 major airports on Friday, with 10% reductions possible by Nov. 14 and a warning from the Transportation Secretary that cuts could hit 20% if controller staffing deteriorates. That scenario would ripple through holiday travel and airline operations, adding another macro headwind.

Leadership & laggards: staples steady, chips slump

A defensive tilt showed up in ETFs as Consumer Staples (XLP) outperformed while Semiconductors (XSD) lagged—classic late‑week positioning when growth volatility spikes.

Semis and broader tech remained under pressure amid AI valuation jitters and profit‑taking, a theme that dominated this week’s cross‑asset narrative and pushed the Nasdaq to that April‑style weekly drawdown.

Stocks to watch

  • Expedia (EXPE): Shares surged after the company raised its 2025 revenue growth outlook, highlighting strength in B2B and resilient U.S. travel demand.
  • Block (SQ):Dropped as investors focused on margin and risk questions following its update.
  • Take‑Two (TTWO):Fell after Rockstar pushed Grand Theft Auto VI to Nov. 19, 2026—the second delay—tempering near‑term bookings enthusiasm.
  • Tesla (TSLA): Investors digested the shareholder approval of Elon Musk’s record $1 trillion compensation plan, tied to aggressive AI/robotics and scale milestones.
  • Microchip Technology (MCHP): Weighed on chips after downbeat guidance earlier in the session.

ETFs & flows: unusual activity on the tape

The SMART Earnings Growth 30 ETF (SGRT) printed unusually high volume relative to its 3‑month average, a sign of tactical repositioning as traders rotated between growth factors.

Europe & deals: Euronext turns the screw on ATHEX bid

Euronext formally lowered the minimum acceptance threshold to 50% + 1 share in its all‑share offer for Hellenic Exchanges (ATHEX), reducing execution risk ahead of the Nov. 17 deadline and keeping its multi‑hub strategy on track. European equities, meanwhile, remained soft into the close on tech nerves.

Why it matters

  • Earnings vs. multiples: With more than four‑fifths of S&P 500 reporters topping estimates, the tug‑of‑war is now about what you pay for growth—especially in AI—rather than whether earnings exist. This week’s pullback shows multiples can compress even with good prints.
  • Macro fog: A data blackout from the shutdown amplifies the impact of private surveys like Michigan sentiment, elevating their market‑moving power and complicating the Fed’s signaling.
  • Travel and consumer spillovers: Forced flight reductions threaten holiday logistics, while low sentiment is historically correlated with softer discretionary outlays—both relevant for Q4 earnings setup.

The road ahead

Next week’s calendar features another heavy stretch of corporate updates and any fresh read‑through on labor and inflation from private‑sector trackers, which may sway odds around the December Fed meeting. Markets will also watch for further shutdown negotiations, aviation staffing trends, and whether tech breadth stabilizes after an AI‑led shakeout.


Sources

Closing levels, weekly context and sector tone are compiled from Reuters market wraps and related coverage; ETF and single‑name moves corroborated with Nasdaq, ETF Channel, and company‑specific reports: mixed close & worst‑since‑April week; Expedia, Block, MCHP, sentiment/yields/dollar; shutdown flight cuts; Tesla vote; GTA VI delay; Euronext‑ATHEX threshold; ETF/sector movers.

This article reflects developments through U.S. market close on Friday, November 7, 2025.

Stock Market Today

  • UBS Boosts Jazz Pharma Stock Price Target to $307 Ahead of FDA Decision
    May 23, 2026, 2:29 PM EDT. UBS upgraded Jazz Pharmaceuticals (JAZZ) stock from neutral to buy, raising its price target by 63% to $307 from $188. This surge exceeds the prior consensus of $242 and follows strong Q1 results, with revenue up 19% year-over-year and oncology portfolio growth of 45%. The move anticipates FDA approval on August 25 of Zanidatamab (Ziihera) for HER2-positive gastroesophageal cancer, expected to generate peak sales of $3.1 billion. UBS projects 10% revenue and 11% earnings growth from 2026-2030, versus consensus of around 7% and 6%, and supports a valuation multiple increase from 7x to 10x earnings, reflecting confidence in sustainable growth. Key risks include FDA delays, slower oncology sales ramp, and underperformance of core franchises like Xywav and Epidiolex.

Latest articles

AbbVie Shares Edge Up Ahead Of Holiday On Pipeline News

AbbVie Shares Edge Up Ahead Of Holiday On Pipeline News

23 May 2026
AbbVie shares closed Friday at $215.70, up 0.56%, gaining 2.5% for the week. The company reported a positive European panel recommendation for MAVIRET in acute hepatitis C and released new oncology data ahead of the ASCO meeting. U.S. markets are closed Monday for Memorial Day, with trading set to resume Tuesday.
Coherent Shares Trade Close to $378, With Next Test Set for Tuesday After Volatile AI-Optics Week

Coherent Shares Trade Close to $378, With Next Test Set for Tuesday After Volatile AI-Optics Week

23 May 2026
Coherent Corp. shares closed at $377.57 Friday, down 0.1% for the day and 1.3% below last week, underperforming the S&P 500 and Nasdaq ahead of the Memorial Day market closure. The company reported fiscal Q3 revenue of $1.81 billion, up 21% year-over-year, with strong demand in datacenter and communications. Nvidia invested $2 billion in March and signed a multi-year optics agreement. Coherent trades at 179 times trailing earnings.
Intuit Slashes 3,000 Jobs as TurboTax Faces New AI Threats

Intuit Slashes 3,000 Jobs as TurboTax Faces New AI Threats

23 May 2026
Intuit will cut about 3,000 jobs, or 17% of its workforce, and close offices in Reno and Woodland Hills as it restructures to focus on artificial intelligence. The company expects $300 million to $340 million in charges, mostly in the fiscal fourth quarter. Intuit raised full-year revenue guidance but lowered its TurboTax outlook, citing pressure from low-cost AI tools. Shares last traded at $319.94 after a volatile week.
Record 2026 Tax Refund Surge Looms as New Tax Cuts Fuel a $50 Billion “Stimulus”
Previous Story

Walmart News Today (Nov. 7, 2025): Re‑Grand Openings Across the U.S., Salvation Army Partnership, and Thanksgiving Price Debate

NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook
Next Story

Nvidia (NVDA) Stock Today — November 7, 2025: Closes Near $188 As China Sales Face New Blocks, AI-Spending Jitters Weigh On Tech

Go toTop